Clinical applications of Molzym’s broad spectrum molecular diagnostics
23 June 2022

In this white paper, results from multi-site studies support Molzym’s Molecular Diagnostic Test (MMDx) performance as a precise and rapid tool for the identification of pathogens – growing or static - directly from samples against reference methods, in various clinical applications. The results highlight MMDx potential to optimize laboratory workflow, provide targeted and clinically relevant information to physicians, thus assisting them to improve patients’ outcomes.